Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Corporate Reputation of Pharma Companies, 2016-2017 Perspective of 75 Italian Patient Groups (2017 Edition) - Research and Markets

Research and Markets
Posted on: 27 Oct 17

The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 75 Italian Patient Groups (3rd Edition)" report has been added to Research and Markets' offering.

These results are derived from a global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

These results are based on the opinions of 75 Italian patient groups (17 specialised in cancer; 10 in diabetes; 6 in HIV/AIDS; and other specialties).

16 pharma companies are included in this 2016 Italian analysis:

  • AbbVie
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly (Lilly)
  • GSK
  • Janssen (Pharmaceutical companies of Johnson & Johnson)
  • Menarini
  • Merck & Co
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Teva

The 16 companies were chosen because a minimum of 19 Italian patient groups declared familiarity with each one.

In response to a survey of pharmaceutical companies, Eisai provided information on its patient centricity and its relations with patient-advocacy groups during 2016-2017 in Italy.

THE QUESTIONNAIRE

Industry-wide questions:

  • How the pharma industry's corporate reputation compares with that of other healthcare industries.
  • How the pharma industry's corporate reputation has changed over the past five years.
  • How good or bad the pharma industry is at various activities of relevance to patients and patient groups.

7 indicators show the corporate reputation of individual pharma companies:

  • Patient centricity.
  • Information for patients.
  • Patient safety.
  • Usefulness of products.
  • Transparency.
  • Integrity.
  • Patient-group relationships (new for 2016).

For more information about this report visit https://www.researchandmarkets.com/research/gndpbk/the_corporate

View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005278/en/

Business Wire
www.businesswire.com

Last updated on: 27/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.